PAPER Zhu J, Liu X, Zheng J, Jiang D
SEARCH RESULTS
335 RESULTS
PAPER Zare D, Rajizadeh MA, Maneshian M, Jonaidi H, Sheibani V, Asadi-Shekaari M, Yousefi M, Esmaeilpour K
Inhibition of protease-activated receptor 1 (PAR1) ameliorates cognitive performance and synaptic plasticity impairments in animal model of Alzheimer's diseases.
Psychopharmacology (Berl). 2021 Jun;238(6):1645-1656. Epub 2021 Feb 23 PubMed: 33624157PAPER Banerjee TD, Reihl K, Swain M, Torres M, Dagda RK
Mitochondrial PKA Is Neuroprotective in a Cell Culture Model of Alzheimer's Disease.
Mol Neurobiol. 2021 Jul;58(7):3071-3083. Epub 2021 Feb 23 PubMed: 33624140PAPER Li M, Geng R, Li C, Meng F, Zhao H, Liu J, Dai J, Wang X
Dysregulated gene-associated biomarkers for Alzheimer's disease and aging.
Transl Neurosci. 2021 Jan 1;12(1):83-95. Epub 2021 Feb 5 PubMed: 33623715PAPER
Erratum: Serum miR-128 Serves as a Potential Diagnostic Biomarker for Alzheimer's Disease [Corrigendum].
Neuropsychiatr Dis Treat. 2021;17:513. Epub 2021 Feb 16 PubMed: 33623385PAPER Lau JK, Tian M, Shen Y, Lau SF, Fu WY, Fu AK, Ip NY
Melanocortin receptor activation alleviates amyloid pathology and glial reactivity in an Alzheimer's disease transgenic mouse model.
Sci Rep. 2021 Feb 23;11(1):4359. PubMed: 33623128PAPER Diaz-Galvan P, Ferreira D, Cedres N, Falahati F, Hernández-Cabrera JA, Ames D, Barroso J, Westman E
Comparing different approaches for operationalizing subjective cognitive decline: impact on syndromic and biomarker profiles.
Sci Rep. 2021 Feb 23;11(1):4356. PubMed: 33623075PAPER Hertel A, Wenz H, Al-Zghloul M, Hausner L, FrÖlich L, Groden C, FÖrster A
Crossed Cerebellar Diaschisis in Alzheimer's Disease Detected by Arterial Spin-labelling Perfusion MRI.
In Vivo. 2021 Mar-Apr;35(2):1177-1183. PubMed: 33622918PAPER Giannini LA, Peterson C, Ohm D, Xie SX, McMillan CT, Raskovsky K, Massimo L, Suh E, Van Deerlin VM, Wolk DA, Trojanowski JQ, Lee EB, Grossman M, Irwin DJ
Frontotemporal lobar degeneration proteinopathies have disparate microscopic patterns of white and grey matter pathology.
Acta Neuropathol Commun. 2021 Feb 23;9(1):30. PubMed: 33622418PAPER Nous A, Engelborghs S, Smolders I
Melatonin levels in the Alzheimer's disease continuum: a systematic review.
Alzheimers Res Ther. 2021 Feb 23;13(1):52. PubMed: 33622399PAPER Phillips MC, Deprez LM, Mortimer GM, Murtagh DK, McCoy S, Mylchreest R, Gilbertson LJ, Clark KM, Simpson PV, McManus EJ, Oh JE, Yadavaraj S, King VM, Pillai A, Romero-Ferrando B, Brinkhuis M, Copeland BM, Samad S, Liao S, Schepel JA
Randomized crossover trial of a modified ketogenic diet in Alzheimer's disease.
Alzheimers Res Ther. 2021 Feb 23;13(1):51. PubMed: 33622392PAPER Zheng X, Lin W, Jiang Y, Lu K, Wei W, Huo Q, Cui S, Yang X, Li M, Xu N, Tang C, Song JX
Electroacupuncture ameliorates beta-amyloid pathology and cognitive impairment in Alzheimer disease via a novel mechanism involving activation of TFEB (transcription factor EB).
Autophagy. 2021 Feb 23;:1-15. PubMed: 33622188PAPER Wu JJ, Yao M, Ni J
Cerebral amyloid angiopathy-related inflammation: current status and future implications.
Chin Med J (Engl). 2021 Feb 23;134(6):646-654. PubMed: 33625036PAPER Sotoudeh H, Sarrami AH, Wang JX, Saadatpour Z, Razaei A, Gaddamanugu S, Choudhary G, Shafaat O, Singhal A
Susceptibility-Weighted Imaging in Neurodegenerative Disorders: A Review.
J Neuroimaging. 2021 May;31(3):459-470. Epub 2021 Feb 23 PubMed: 33624404PAPER Zhang SC, Jia JJ, Zhao HL, Zhou B, Wang W, Lu XH, Wang H, Wang ZF, Wu WP
Early MRI imaging and follow-up study in cerebral amyloid angiopathy.
Open Med (Wars). 2021;16(1):257-263. Epub 2021 Feb 2 PubMed: 33623821Current Filters
- Date Range : Feb 2021 to Mar 2021 x